Peter Hammerer

1.3k total citations
52 papers, 868 citations indexed

About

Peter Hammerer is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Peter Hammerer has authored 52 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 10 papers in Oncology. Recurrent topics in Peter Hammerer's work include Prostate Cancer Treatment and Research (29 papers), Prostate Cancer Diagnosis and Treatment (20 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Peter Hammerer is often cited by papers focused on Prostate Cancer Treatment and Research (29 papers), Prostate Cancer Diagnosis and Treatment (20 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Peter Hammerer collaborates with scholars based in Germany, United States and France. Peter Hammerer's co-authors include Antonio Alcaraz, Ramiro Castro, Fritz H. Schröder, Andrea Tubaro, Markus Graefen, Hartwig Huland, Andreas Erbersdobler, Christian G. Stief, Aksam Yassin and V. Ravery and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and The Journal of Urology.

In The Last Decade

Peter Hammerer

50 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Hammerer Germany 15 478 190 176 155 140 52 868
Göran Ahlgren Sweden 18 943 2.0× 174 0.9× 170 1.0× 194 1.3× 78 0.6× 45 1.2k
Christopher Pieczonka United States 12 433 0.9× 56 0.3× 136 0.8× 142 0.9× 122 0.9× 69 679
Ignacio F. San Francisco Chile 16 588 1.2× 157 0.8× 95 0.5× 139 0.9× 44 0.3× 35 823
Hideyo Miyazaki Japan 14 318 0.7× 408 2.1× 299 1.7× 147 0.9× 102 0.7× 38 933
Thomas Schnoeller Germany 14 557 1.2× 147 0.8× 166 0.9× 209 1.3× 90 0.6× 23 791
Francisco Pina Portugal 12 354 0.7× 177 0.9× 144 0.8× 86 0.6× 57 0.4× 34 680
Jian Pan China 13 338 0.7× 214 1.1× 176 1.0× 231 1.5× 114 0.8× 52 836
Marie C. Hupe Germany 14 355 0.7× 169 0.9× 118 0.7× 162 1.0× 29 0.2× 57 661
David Grignon United States 12 669 1.4× 156 0.8× 95 0.5× 283 1.8× 97 0.7× 26 965
Friedemann Zengerling Germany 16 339 0.7× 207 1.1× 205 1.2× 369 2.4× 24 0.2× 102 777

Countries citing papers authored by Peter Hammerer

Since Specialization
Citations

This map shows the geographic impact of Peter Hammerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hammerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hammerer more than expected).

Fields of papers citing papers by Peter Hammerer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hammerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hammerer. The network helps show where Peter Hammerer may publish in the future.

Co-authorship network of co-authors of Peter Hammerer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hammerer. A scholar is included among the top collaborators of Peter Hammerer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hammerer. Peter Hammerer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manka, Lukas, Zhe Tian, Alexander Winter, et al.. (2020). Elastography Targeted Prostate Biopsy in Patients under Active Surveillance. Urologia Internationalis. 104(11-12). 948–953. 1 indexed citations
2.
Hammerer, Peter & Lukas Manka. (2019). Einsatz von Docetaxel oder Abirateron in Kombination mit einer Androgendeprivationstherapie beim metastasierten hormonnaiven Prostatakarzinom. Der Urologe. 58(10). 1185–1197. 2 indexed citations
3.
Manka, Lukas, Andreas Beck, Alexander Winter, et al.. (2019). Only Size Matters in Stone Patients: Computed Tomography Controlled Stone-Free Rates after Mini-Percutaneous Nephrolithotomy. Urologia Internationalis. 103(2). 166–171. 17 indexed citations
4.
Sooriakumaran, Prasanna, Jeffrey Karnes, Christian G. Stief, et al.. (2015). A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation. European Urology. 69(5). 788–794. 117 indexed citations
5.
6.
Merseburger, Axel S., Peter Hammerer, François Rozet, et al.. (2014). Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy?. World Journal of Urology. 33(8). 1079–1085. 29 indexed citations
7.
Haider, Ahmad, Michael Zitzmann, Gheorghe Doros, et al.. (2014). Incidence of Prostate Cancer in Hypogonadal Men Receiving Testosterone Therapy: Observations from 5-Year Median Followup of 3 Registries. The Journal of Urology. 193(1). 80–86. 65 indexed citations
8.
Zugor, Vahudin, et al.. (2010). TVT vs. TOT: a comparison in terms of continence results, complications and quality of life after a median follow-up of 48 months. International Urology and Nephrology. 42(4). 915–920. 12 indexed citations
9.
Jeron, Andreas, Dunja Bruder, Robert Geffers, et al.. (2009). Frequency and Gene Expression Profile of Regulatory T Cells in Renal Cell Carcinoma. Tumor Biology. 30(3). 160–170. 16 indexed citations
10.
Montorsi, Francesco, Antonio Alcaraz, François Desgrandchamps, et al.. (2009). A broader role for 5ARIs in prostate disease? Existing evidence and emerging benefits. The Prostate. 69(8). 895–907. 9 indexed citations
11.
Tilki, Derya, Ster Irmak, Leticia Oliveira‐Ferrer, et al.. (2006). CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. Oncogene. 25(36). 4965–4974. 52 indexed citations
12.
Sieverding, Monika, Paolo Fornara, Markus Graefen, et al.. (2006). PSA 2010 – Aufbruch in eine neue Ära der Früherkennung des Prostatakarzinom. Der Urologe. 45(S04). 127–133. 2 indexed citations
13.
Mottet, Nicolas, T. Prayer-Galetti, Peter Hammerer, Michael W. Kattan, & U. Tunn. (2006). Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer. British Journal of Urology. 98(1). 20–27. 35 indexed citations
14.
Hautmann, S., Martin Friedrich, Salvador Fernández, et al.. (2004). Extracorporeal Shockwave Lithotripsy Compared with Ureteroscopy for the Removal of Small Distal Ureteral Stones. Urologia Internationalis. 73(3). 238–243. 11 indexed citations
15.
Friedrich, Martin G., Marieta Toma, Susan Petri, et al.. (2004). Expression of Maspin in Non-Muscle Invasive Bladder Carcinoma: Correlation with Tumor Angiogenesis and Prognosis. European Urology. 45(6). 737–743. 34 indexed citations
16.
Kuczyk, M.A., Levent Türkeri, Peter Hammerer, & V. Ravery. (2003). Is There a Role for Bladder Preserving Strategies in the Treatment of Muscle-Invasive Bladder Cancer?. European Urology. 44(1). 57–64. 41 indexed citations
17.
Graefen, Markus, Uwe Michl, Peter Hammerer, & Hartwig Huland. (2000). Potenz und Kontinenz nach radikaler Prostatektomie. Der Onkologe. 6(2). 123–129. 3 indexed citations
18.
Hammerer, Peter, Markus Graefen, Thomas Steuber, & Hartwig Huland. (2000). Chemoprävention des Prostatakarzinoms. Der Urologe. 39(4). 304–308. 1 indexed citations
19.
Huland, Hartwig, Markus Graefen, Peter Hammerer, et al.. (1999). MULTIVARIATE ANALYSIS OF PREOPERATIVE PARAMETERS FOR PREDICTION OF EARLY PSA RELAPSE AFTER RADICAL PROSTATECTOMY (RP). The Journal of Urology. 334–334. 1 indexed citations
20.
Hammerer, Peter, et al.. (1988). Aspiration cytology of liver transplants.. PubMed. 20(4). 640–1. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Göran Ahlgren Breakdown of academic impact, for papers by Christopher Pieczonka Breakdown of academic impact, for papers by Ignacio F. San Francisco Breakdown of academic impact, for papers by Hideyo Miyazaki Breakdown of academic impact, for papers by Thomas Schnoeller Breakdown of academic impact, for papers by Francisco Pina Breakdown of academic impact, for papers by Jian Pan Breakdown of academic impact, for papers by Marie C. Hupe Breakdown of academic impact, for papers by David Grignon Breakdown of academic impact, for papers by Friedemann Zengerling
Rankless by CCL
2026